Mancini, I.
Agosti, P.
Boscarino, M.
Ferrari, B.
Artoni, A.
Palla, R.
Spreafico, M.
Crovetti, G.
Volpato, E.
Rossini, S.
Novelli, C.
Gattillo, S.
Barcella, L.
Salmoiraghi, M.
Falanga, A.
Peyvandi, F. https://orcid.org/0000-0001-7423-9864
,
Peyvandi, Flora
Artoni, Andrea
Ferrari, Barbara
Palla, Roberta
Mancini, Ilaria
Agosti, Pasquale
Spreafico, Marta
Crovetti, Giovanni
Volpato, Elisabetta
Rossini, Silvano
Falanga, Anna
Russo, Laura
Barcella, Luca
Gattillo, Salvatore
Novelli, Chiara
Capuzzo, Enrico
D’Agostino, Marco
Moreno, Porcari
Alessandro, Inzoli
Ambrogio, Pagani
Funding for this research was provided by:
Regione Lombardia (Decreto n. 9269, 18/10/2012)
Ministero della Salute (Bando Ricerca Corrente)
Article History
Received: 19 November 2021
Accepted: 12 June 2022
First Online: 23 June 2022
Declarations
:
: This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico (Date: 18/12/2013/No: 123). Written informed consent was obtained from all subjects included in the study.
: Not applicable.
: Ilaria Mancini received honoraria for participating as a speaker at educational meetings organized by Instrumentation Laboratory and Sanofi-Genzyme, outside the present study. Barbara Ferrari received honoraria for participating to a Sanofi advisory board meeting, outside the present study. Roberta Palla received honoraria for participating as a speaker at educational meetings organized by Novonordisk, outside the present study. Chiara Novelli received honoraria for participating as a speaker at educational meetings and as a scientific advisor by Instrumentation Laboratory, outside the present study. Anna Falanga received honoraria for participating as a speaker at satellite symposia and educational meetings organized by Sanofi, Bayer, Roche, Leo Pharma, Stago, and Pfizer, outside the present study. Flora Peyvandi received honoraria for participating as a speaker in educational meetings/advisory boards organized by Roche, Sobi, Sanofi and Takeda, outside the present study. The other authors do not have any conflict of interest to disclose.